Avidity Biosciences Inc
Market Cap
$10.63B
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$21.51 — $73.06
Volume
1
Avg Volume
2.70M
Beta
0.93
Get alerted when RNAM hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.34
P/S (TTM)
600.12
P/B (TTM)
6.44
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.45%
ROA (TTM)
-0.35%
ROIC
—
Gross Margin
0.78%
Operating Margin
-39.77%
Net Margin
—
Debt/Equity
0.06
Current Ratio
9.20
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.19%
EPS Growth (5Y)
-0.23%
Sales Growth (3Y)
+0.30%
Sales Growth (5Y)
+0.25%
EPS Est (This Year)
$-5.19
EPS Est (Next Year)
$-3.79
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$11.37
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-06-12
Employees
511
CEO
Sarah Boyce
Index Membership
—
Website
http://www.aviditybiosciences.com
Avidity Biosciences Inc (RNAM) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $10.63B, RNAM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RNAM against other stocks using dozens of fundamental and technical filters.
No, Avidity Biosciences Inc (RNAM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Avidity Biosciences Inc (RNAM) has a market capitalization of $10.63 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.